Batalini, Felipe https://orcid.org/0000-0003-3354-308X
Gulhan, Doga C. https://orcid.org/0000-0001-5419-0549
Mao, Victor https://orcid.org/0000-0001-5051-2459
Tran, Antuan https://orcid.org/0000-0002-3911-1686
Polak, Madeline https://orcid.org/0000-0002-1331-3845
Xiong, Niya https://orcid.org/0000-0003-2496-9409
Tayob, Nabihah https://orcid.org/0000-0001-6088-167X
Tung, Nadine M. https://orcid.org/0000-0003-1422-3734
Winer, Eric P. https://orcid.org/0000-0002-8819-1723
Mayer, Erica L. https://orcid.org/0000-0001-5430-8957
Knappskog, Stian https://orcid.org/0000-0002-4153-1655
Lønning, Per E. https://orcid.org/0000-0002-8890-6303
Matulonis, Ursula A. https://orcid.org/0000-0002-3103-6992
Konstantinopoulos, Panagiotis A. https://orcid.org/0000-0002-1032-1479
Solit, David B. https://orcid.org/0000-0002-6614-802X
Won, Helen https://orcid.org/0000-0001-5237-7529
Eikesdal, Hans P. https://orcid.org/0000-0003-4086-0147
Park, Peter J. https://orcid.org/0000-0001-9378-960X
Wulf, Gerburg M. https://orcid.org/0000-0001-7868-6231
Funding for this research was provided by:
National Cancer Institute (P50 CA168504)
National Cancer Institute (P50 CA240243-01A1)
National Cancer Institute (1R01CA226776-01)
Stand Up To Cancer (SU2C-AACR-DT0209)
Stiftelsen Kristian Gerhard Jebsen (SKGJ-MED-020)
AstraZeneca (ESR-14-10077)
Pfizer UK (GMGS #51752519)
Helse Vest (#912252 & 912008)
Kreftforeningen (190281-2017 & 190275-2017)
Norwegian Research Council (273354)